Product Description
Anoreigenic. It is indicated in the treatment of overweight patients (body mass index equal to or greater than 27 kg / m2 [patients with short stature, body mass index equal to or greater than 25 kg / m2]); as well as in patients with obesity (body mass index equal to or greater than 30 kg / m2); with any associated pathology and who have not responded to diet and physical activity appropriately. It is suggested to carry out a program of physical activity and diet simultaneously with treatment with Clobenzorex.